Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Go back to Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares| (NASDAQ: DNTH) | Delayed: 95.76 +2.42 (2.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.34 | 52 Week High | $ | |||
| Open | $93.34 | 52 Week Low | $ | |||
| Day High | $96.88 | P/E | N/A | |||
| Day Low | $92.46 | EPS | $ | |||
| Volume | 819,572 | |||||
